InsidersTradesSigma
Track the 沃华医药 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 沃华医药 has recorded 5 reports. Market capitalisation: €3.6bn. The latest transaction was disclosed on 11 June 2026 (Sale). Among the most active insiders: 张戈. All data is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€650,114
5 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,750 of 29,063 companies
61.4
score / 100
Value38
Quality85
FCF yld3.1%
Earn yld2.3%
EV/EBITDA31.2x
ROE16%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 June 2026
Declarations5 total
5 of 5 declarations
Acerca de 沃华医药
沃华医药 es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XSHE.